Pentapeptide-18

Also known as: Leuphasyl, Leuphasyl®, D-Ala²-Leucine-Enkephalin

CAS: 64963-01-5

Summary

Pentapeptide-18 is a synthetic neuropeptide (Tyr-D-Ala-Gly-Phe-Leu) that mimics the mechanism of enkephalins to reduce expression wrinkles. It works by modulating calcium channels in neurons to inhibit acetylcholine release, thereby reducing muscle contractions that cause wrinkles. Clinical studies demonstrate 11-34% wrinkle reduction with topical application, with enhanced efficacy when combined with other neuropeptides like Argireline. Pentapeptide-18 is considered a non-invasive, topical alternative to botulinum toxin injections.

Potential Benefits

Anti-Wrinkle Efficacy

Pentapeptide-18 demonstrates clinically proven wrinkle reduction through neurotransmitter inhibition. Studies show 11.64% wrinkle reduction when used alone at 0.05% concentration over 28 days [1]. At higher concentrations (2%), clinical trials demonstrated 34.7% wrinkle reduction in the frontal region and 28.4% in the periorbital area after 2 months [2].

Mechanism of Action

The peptide mimics natural enkephalins by binding to enkephalin receptors on nerve cells, modulating calcium channels to prevent acetylcholine release across the synapse [3]. This results in reduced muscle contractions and decreased expression wrinkles without paralysis [4]. The mechanism involves decreasing glutamate release by approximately 11% [1].

Synergistic Effects

When combined with Acetyl Hexapeptide-3 (Argireline), Pentapeptide-18 shows enhanced efficacy with wrinkle reductions of 24.62% compared to 11.64% alone [1]. The combination of 5% Leuphasyl and 5% Argireline achieved maximum wrinkle reductions up to 47% [5]. These synergistic effects occur because the peptides target different mechanisms within the neurotransmitter release pathway [2][6].

Additional Skin Benefits

Beyond wrinkle reduction, Pentapeptide-18 derivatives containing D-tyrosine demonstrate dual anti-wrinkle and skin whitening properties by reducing melanin content and tyrosinase activity in melanocytes [7]. Modified versions of Pentapeptide-18 can decrease melanogenesis without altering the peptide's intrinsic anti-wrinkle effects [7].

Non-Invasive Alternative

Pentapeptide-18 offers a topical, non-invasive alternative to botulinum toxin injections while preserving natural facial expression [2][8]. Unlike Botox, it provides gradual improvements without adverse effects, though results are more subtle and require consistent application [4][9].

Clinical Applications

Pentapeptide-18 is incorporated into various anti-aging formulations including oil-in-water creams, serums, and advanced delivery systems. Recent formulations using solid lipid nanoparticles with Pentapeptide-18 and retinol show improved stability and enhanced wrinkle reduction after 8 weeks [6][10].

Safety Information

Safety Profile

Pentapeptide-18 demonstrates excellent safety in cosmetic applications. Clinical studies report the ingredient is "absolutely free from side effects" while maintaining facial expressivity [2]. The Expert Panel for Cosmetic Ingredient Safety evaluated skin and connective tissue-derived peptides and concluded they are safe in current cosmetic use practices [11].

Toxicity and Allergenicity

No significant toxicity has been reported in clinical trials involving topical application of Pentapeptide-18 [2][4]. Peptides generally exhibit low immunogenicity compared to other biologic therapeutics, though hypo-allergenicity should be evaluated before widespread clinical use [12]. No adverse reactions were reported in studies involving up to 60 participants using the peptide twice daily for 2-4 months [2].

Recommended Concentrations

Clinical efficacy is demonstrated at minimum concentrations of 2% [2][8]. Lower concentrations (0.05-0.5%) show modest effects, while 2% concentration provides optimal wrinkle reduction without adverse effects [1][2]. The ingredient is typically formulated in oil-in-water or water-in-water creams at 2% for maximum efficacy [8].

Skin Penetration

Like other cosmetic peptides, Pentapeptide-18 faces challenges with dermal penetration due to its molecular weight (569.6 g/mol) [8]. Advanced delivery systems including solid lipid nanoparticles and enhanced formulations improve penetration and stability [10][13]. The peptide's efficacy depends on proper formulation to overcome the skin barrier [12].

Regulatory Status

Pentapeptide-18 (CAS 64963-01-5) is approved for cosmetic use and is manufactured by Lipotec S.A. in Barcelona, Spain [6][14]. Under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), manufacturers must ensure safety assessments including stability, skin penetration efficiency, and allergenicity [12].

Contraindications

No specific contraindications have been reported in the literature. The ingredient is suitable for topical cosmetic use in adults. As with all cosmetic peptides, individuals with known peptide allergies should exercise caution [12].

Available Suppliers & Pricing

No pricing information available for this peptide

All peptides are for research purposes only. Not for human consumption.

Affiliate Disclosure: Peptide Plus may earn commissions from purchases made through supplier links.

© 2025 Chippy Labs LLC · Made with ❤️